Share on StockTwits

Shares of Thermo Fisher Scientific (NYSE:TMO) have been given a consensus rating of “Buy” by the seventeen ratings firms that are covering the company, Stock Ratings News reports. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $112.53.

TMO has been the subject of a number of recent research reports. Analysts at JPMorgan Chase & Co. initiated coverage on shares of Thermo Fisher Scientific in a research note on Tuesday. They set an “overweight” rating and a $135.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Thermo Fisher Scientific in a research note on Tuesday, February 4th. They now have a $121.00 price target on the stock. Finally, analysts at Leerink Swann raised their price target on shares of Thermo Fisher Scientific from $107.00 to $130.00 in a research note on Friday, January 31st. They now have an “outperform” rating on the stock.

In other Thermo Fisher Scientific news, CAO Peter E. Hornstra unloaded 9,234 shares of the company’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $117.72, for a total value of $1,087,026.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Shares of Thermo Fisher Scientific (NYSE:TMO) traded down 0.07% during mid-day trading on Wednesday, hitting $120.915. The stock had a trading volume of 885,471 shares. Thermo Fisher Scientific has a 1-year low of $71.60 and a 1-year high of $121.21. The stock’s 50-day moving average is $113.3 and its 200-day moving average is $99.74. The company has a market cap of $43.747 billion and a P/E ratio of 34.73.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Friday, January 31st. The company reported $1.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.38 by $0.05. The company had revenue of $3.47 billion for the quarter, compared to the consensus estimate of $3.31 billion. On average, analysts predict that Thermo Fisher Scientific will post $6.81 earnings per share for the current fiscal year.

Thermo Fisher Scientific Inc (NYSE:TMO) is engaged in serving science.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.